---
authors:
- Kulkarni, Nita Shrikant
category: Case Study
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36379479/
file_path: 2022/11/use-of-procalcitonin-guidance-reduces-antibiotic-duration-in.md
issue: '5'
keywords:
- Humans
- Patients
- Biomarkers
- Calcitonin
- Anti-Bacterial Agents
- Procalcitonin
- Drug Administration Schedule
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Procalcitonin
- Anti-Bacterial Agents
- Calcitonin
- Drug Administration Schedule
- Patients
- Biomarkers
original_format: PubMed
pages: '584'
patient_population: Adults
peer_reviewed: true
pmid: '36379479'
processed_date: '2025-07-30'
publication_date: '2022-11-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Use of Procalcitonin Guidance Reduces Antibiotic Duration in Hospitalized Patients.
topics:
- Family Medicine
volume: '106'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36379479'
  title: Use of Procalcitonin Guidance Reduces Antibiotic Duration in Hospitalized
    Patients.
  authors:
  - last_name: Kulkarni
    fore_name: Nita Shrikant
    initials: NS
    affiliation: Northwestern University, Chicago, Ill.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '106'
    issue: '5'
  publication_info:
    year: '2022'
    month: '11'
    full_date: '2022-11-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Procalcitonin
    major_topic: true
  - descriptor: Anti-Bacterial Agents
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Calcitonin
    major_topic: false
  - descriptor: Drug Administration Schedule
    major_topic: false
  - descriptor: Patients
    major_topic: false
  - descriptor: Biomarkers
    major_topic: false
  publication_types: *id001
related_articles:
- pmid: '36379479'
  title: Use of Procalcitonin Guidance Reduces Antibiotic Duration in Hospitalized
    Patients.
  authors:
  - name: Kulkarni NS
    authtype: Author
    clusterid: ''
  source: Am Fam Physician
  pubdate: 2022 Nov
- pmid: '26947523'
  title: 'Efficacy and safety of procalcitonin guidance in reducing the duration of
    antibiotic treatment in critically ill patients: a randomised, controlled, open-label
    trial.'
  authors:
  - name: de Jong E
    authtype: Author
    clusterid: ''
  - name: van Oers JA
    authtype: Author
    clusterid: ''
  - name: Beishuizen A
    authtype: Author
    clusterid: ''
  - name: Vos P
    authtype: Author
    clusterid: ''
  - name: Vermeijden WJ
    authtype: Author
    clusterid: ''
  - name: Haas LE
    authtype: Author
    clusterid: ''
  - name: Loef BG
    authtype: Author
    clusterid: ''
  - name: Dormans T
    authtype: Author
    clusterid: ''
  - name: van Melsen GC
    authtype: Author
    clusterid: ''
  - name: Kluiters YC
    authtype: Author
    clusterid: ''
  - name: Kemperman H
    authtype: Author
    clusterid: ''
  - name: van den Elsen MJ
    authtype: Author
    clusterid: ''
  - name: Schouten JA
    authtype: Author
    clusterid: ''
  - name: Streefkerk JO
    authtype: Author
    clusterid: ''
  - name: Krabbe HG
    authtype: Author
    clusterid: ''
  - name: Kieft H
    authtype: Author
    clusterid: ''
  - name: Kluge GH
    authtype: Author
    clusterid: ''
  - name: van Dam VC
    authtype: Author
    clusterid: ''
  - name: van Pelt J
    authtype: Author
    clusterid: ''
  - name: Bormans L
    authtype: Author
    clusterid: ''
  - name: Otten MB
    authtype: Author
    clusterid: ''
  - name: Reidinga AC
    authtype: Author
    clusterid: ''
  - name: Endeman H
    authtype: Author
    clusterid: ''
  - name: Twisk JW
    authtype: Author
    clusterid: ''
  - name: van de Garde EMW
    authtype: Author
    clusterid: ''
  - name: de Smet AMGA
    authtype: Author
    clusterid: ''
  - name: Kesecioglu J
    authtype: Author
    clusterid: ''
  - name: Girbes AR
    authtype: Author
    clusterid: ''
  - name: Nijsten MW
    authtype: Author
    clusterid: ''
  - name: de Lange DW
    authtype: Author
    clusterid: ''
  source: Lancet Infect Dis
  pubdate: 2016 Jul
- pmid: '16603606'
  title: 'Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia:
    a randomized trial.'
  authors:
  - name: Christ-Crain M
    authtype: Author
    clusterid: ''
  - name: Stolz D
    authtype: Author
    clusterid: ''
  - name: Bingisser R
    authtype: Author
    clusterid: ''
  - name: Müller C
    authtype: Author
    clusterid: ''
  - name: Miedinger D
    authtype: Author
    clusterid: ''
  - name: Huber PR
    authtype: Author
    clusterid: ''
  - name: Zimmerli W
    authtype: Author
    clusterid: ''
  - name: Harbarth S
    authtype: Author
    clusterid: ''
  - name: Tamm M
    authtype: Author
    clusterid: ''
  - name: Müller B
    authtype: Author
    clusterid: ''
  source: Am J Respir Crit Care Med
  pubdate: 2006 Jul 1
- pmid: '28024740'
  title: Impact of procalcitonin-guided therapy for hospitalized community-acquired
    pneumonia on reducing antibiotic consumption and costs in Japan.
  authors:
  - name: Ito A
    authtype: Author
    clusterid: ''
  - name: Ishida T
    authtype: Author
    clusterid: ''
  - name: Tokumasu H
    authtype: Author
    clusterid: ''
  - name: Washio Y
    authtype: Author
    clusterid: ''
  - name: Yamazaki A
    authtype: Author
    clusterid: ''
  - name: Ito Y
    authtype: Author
    clusterid: ''
  - name: Tachibana H
    authtype: Author
    clusterid: ''
  source: J Infect Chemother
  pubdate: 2017 Mar
- pmid: '23590389'
  title: 'Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised
    prospective multicenter investigator-initiated trial to analyse whether daily
    measurements of procalcitonin versus a standard-of-care approach can safely shorten
    antibiotic duration in intensive care unit patients--calculated sample size: 1816
    patients.'
  authors:
  - name: Assink-de Jong E
    authtype: Author
    clusterid: ''
  - name: de Lange DW
    authtype: Author
    clusterid: ''
  - name: van Oers JA
    authtype: Author
    clusterid: ''
  - name: Nijsten MW
    authtype: Author
    clusterid: ''
  - name: Twisk JW
    authtype: Author
    clusterid: ''
  - name: Beishuizen A
    authtype: Author
    clusterid: ''
  source: BMC Infect Dis
  pubdate: 2013 Apr 16
---

# Use of Procalcitonin Guidance Reduces Antibiotic Duration in Hospitalized Patients.

**Authors:** Kulkarni, Nita Shrikant

**Published in:** American family physician | Vol. 106, No. 5 | 2022-11-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36379479/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Procalcitonin, Anti-Bacterial Agents, Calcitonin, Drug Administration Schedule, Patients, Biomarkers

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36379479/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
